ArticleRSC advances2021
Effect of hydrothermal aging temperature on a Cu-SSZ-13/H-SAPO-34 composite for the selective catalytic reduction of NO
Article in RSC advances, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Review of the application of Cu-containing SSZ-13 in NHRSC advances · 2022Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cu-SSZ-13 suffers activity loss after hydrothermal treatment at high temperatures, particularly above 850 °C. The stability of Cu-SSZ-13 can be enhanced by compositing with H-SAPO-34. This work investigates the effect of aging temperature on the composites. For the structure, the extra-framework P in H-SAPO-34 migrates and interacts with the Al in Cu-SSZ-13, forming a new framework P-Al bond. This interaction is enhanced with the increment of the aging temperature. For the cupric sites, the aging at 750 °C results in the agglomeration of Cu
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.